Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Enpro
NPO
$7.22B
| $10.3M | 0.01% |
144,300
+34,200
| +31% | +$2.27M |
|
|
NATI
1227
DELISTED
National Instruments Corp
NATI
| $10.3M | 0.01% |
315,366
-196,100
| -38% | -$6.24M |
|
1228
ArcBest
ARCB
$3.27B
| $10.3M | 0.01% |
394,835
-199,300
| -34% | -$5.85M |
|
1229
Myriad Genetics
MYGN
$303M
| $10.3M | 0.01% |
534,700
-2,151,474
| -80% | -$38.1M |
|
1230
Sterling Infrastructure
STRL
$17B
| $10.3M | 0.01% |
1,109,100
+116,100
| +12% | +$1.06M |
|
1231
Arrow Financial
AROW
$730M
| $10.3M | 0.01% |
372,118
+43,169
| +13% | +$1.25M |
|
1232
RCI Hospitality Holdings
RICK
$225M
| $10.3M | 0.01% |
592,000
+7,200
| +1% | +$122K |
|
1233
Johnson Outdoors
JOUT
$515M
| $10.2M | 0.01% |
280,700
+13,300
| +5% | +$465K |
|
|
THS
1234
DELISTED
Treehouse Foods
THS
| $10.2M | 0.01% |
+121,000
| New | +$9.7M |
|
|
KRA
1235
DELISTED
Kraton Corporation
KRA
| $10.2M | 0.01% |
331,300
+219,791
| +197% | +$6.13M |
|
|
UFS
1236
DELISTED
DOMTAR CORPORATION (New)
UFS
| $10.2M | 0.01% |
280,042
+259,200
| +1,244% | +$10.3M |
|
|
PERY
1237
DELISTED
Perry Ellis International Inc
PERY
| $10.2M | 0.01% |
475,900
-9,800
| -2% | -$226K |
|
|
GBNK
1238
DELISTED
Guaranty Bancorp
GBNK
| $10.2M | 0.01% |
419,620
-12,821
| -3% | -$311K |
|
1239
HUB Group
HUBG
$2.58B
| $10.2M | 0.01% |
439,872
+114,400
| +35% | +$2.7M |
|
1240
Barclays
BCS
$94.5B
| $10.2M | 0.01% |
951,756
-881,078
| -48% | -$9.47M |
|
|
TRST
1241
Trustco Bank Corp NY
TRST
$974M
| $10.2M | 0.01% |
258,600
+12,460
| +5% | +$515K |
|
1242
Mizuho Financial
MFG
$134B
| $10.1M | 0.01% |
2,743,400
-254,118
| -8% | -$944K |
|
|
KAMN
1243
DELISTED
Kaman Corp
KAMN
| $10.1M | 0.01% |
209,922
+91,000
| +77% | +$4.55M |
|
1244
Take-Two Interactive
TTWO
$45.1B
| $10.1M | 0.01% |
170,450
-66,000
| -28% | -$3.69M |
|
1245
FTI Consulting
FCN
$4.15B
| $10.1M | 0.01% |
245,300
-20,300
| -8% | -$843K |
|
|
VLRS
1246
Controladora Vuela Compania de Aviacion
VLRS
$937M
| $10.1M | 0.01% |
724,100
-146,700
| -17% | -$1.97M |
|
1247
First Hawaiian
FHB
$3.39B
| $10.1M | 0.01% |
+336,490
| New | +$10.8M |
|
1248
Fortune Brands Innovations
FBIN
$5.84B
| $10.1M | 0.01% |
193,401
-293,202
| -60% | -$14.4M |
|
|
RNET
1249
DELISTED
RigNet, Inc.
RNET
| $10.1M | 0.01% |
468,600
+38,000
| +9% | +$757K |
|
1250
Great Southern Bancorp
GSBC
$886M
| $10M | 0.01% |
198,500
-2,800
| -1% | -$142K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.